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Abstract 
Organ failure is the leading cause of intensive care 
unit (ICU) mortality. This research evaluates the 
influence of glycemic variability and hypoglycemia 
on organ failure rate. The analysis uses data from 
the Glucontrol study and results show that high 
glycemic variability and hypoglycemia are both 
associated with increased SOFA score, and thus 
increased organ failure rate.   
Keyword(s): medical/clinical engineering – modeling 
of physiological systems 
 
1 Introduction 
Organ failure is a common complication associated 
with increased mortality in intensive care unit (ICU) 
patients. Increased mortality is also related to 
glycemic variability (GV) and hypoglycemia [1]. This 
research evaluates the influence of GV and severe 
hypoglycemia on organ failure rate. 
 
2 Methods 
Daily Sequential Organ Failure Assessment (SOFA) 
score is used to assess organ failure rate. Glycemic 
variability was estimated by a daily glycemic lability 
index. A hypoglycemic event is defined as blood 
glucose (BG) < 2.2 mmol/L. These metrics are 
evaluated for all 704 patients in the Glucontrol study 
(multiple centers) who were treated in matched 
cohorts to two different target glycemic levels [2]. 
The analysis thus considers these glycemic 
outcomes independent of glycemic target. 
 
2.1 GV and SOFA score 
For each day, patients are divided in two groups 
depending if their GV was higher or lower than the 
median GV of the considered day. We compare 
daily SOFA scores (median, IQR, mean) for each 
group using a Mann-Whitney test and p < 0.05 is 
considered significant. 
 
2.2 Hypoglycemia and SOFA score 
Patients are divided in two groups depending 
whether they had a severe hypoglycemic event or 
not during their ICU stay. We compare daily SOFA 
scores (median, IQR, mean) for each group on each 
day using a Mann-Whitney test. 
3 Results 
Patients with high GV have higher SOFA scores 
(Figure 1) but this difference is significant only on 
Days 2-4 (p < 0.05). Figure 2 shows that patients 
who had at least one hypoglycemic event are 
associated with significantly higher SOFA scores (p 
< 0.05 on Days 2-14). These results match those of 
other studies on ICU mortality and glycemic control. 




























Figure 1 - Evolution of mean SOFA score for patients with high GV 
(red) and low GV (blue) 




























Figure 2 - Evolution of mean SOFA score for patients with (red) and 




High glycemic variability and hypoglycemia are both 
associated with increase in SOFA score, and thus 
increase in organ failure rate. 
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